Cold Spring Harbor Lab names Teri Willey as new BD chief

Teri Willey has stepped in to take over as vice president of business development and technology transfer at Cold Spring Harbor Laboratory. She had been doing similar work at Mt. Sinai Medical Center. Willey was also a co-founder at Arch Development Partners, a venture group. The lab says its scientific work has led to the creation of about 20 biotechs, including OSI Pharmaceuticals, which was acquired by Astellas. Release

Suggested Articles

Preclinical-stage biotech Abpro Therapeutics wants to trial its two lead candidates for HER2-positive cancers and diabetic macular edema in 2019.

After a rough patch in 2017, the stars seem to be realigning for French CAR-T expert Cellectis, which just closed a $164 million U.S. public offering.

Investment firm Frazier Healthcare Partners has closed its 11th fund—worth $780 million—that will help established companies accelerate their growth.